Literature DB >> 7978133

A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement.

C McFarlane1, A Lee.   

Abstract

Thirty patients undergoing major hepatobiliary or pancreatic surgery were randomly allocated to receive either 0.9% saline or Plasmalyte 148 (a balanced salt solution), at 15 ml.kg-1.h-1. Arterial blood gas analysis was performed before and after surgery. Plasma biochemistry (Na+, K+, Cl-, lactate) measurements were made before and after surgery and at 24 h after surgery. The patients receiving 0.9% saline had significantly increased chloride concentrations (p < 0.01), decreased standard bicarbonate concentrations (p < 0.01) and increased base deficit (p < 0.01) compared to those receiving Plasmalyte 148. There were no significant changes in plasma sodium or potassium or blood lactate concentrations in either group. The exclusive use of 0.9% saline intra-operatively can produce a temporary hyperchloraemic acidosis which could be given false pathological significance. In addition it may exacerbate an acidosis resulting from an actual pathological state. The use of a balanced salt solution such as Plasmalyte 148 may avoid these complications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978133     DOI: 10.1111/j.1365-2044.1994.tb04450.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  40 in total

1.  The Stewart approach--one clinician's perspective.

Authors:  T John Morgan
Journal:  Clin Biochem Rev       Date:  2009-05

Review 2.  Controversies in fluid therapy: Type, dose and toxicity.

Authors:  Robert C McDermid; Karthik Raghunathan; Adam Romanovsky; Andrew D Shaw; Sean M Bagshaw
Journal:  World J Crit Care Med       Date:  2014-02-04

3.  Choice of crystalloids in sepsis: a conundrum waiting to be solved.

Authors:  Ying Wei Yau; Win Sen Kuan
Journal:  Ann Transl Med       Date:  2016-03

4.  Balanced versus isotonic saline resuscitation-a systematic review and meta-analysis of randomized controlled trials in operation rooms and intensive care units.

Authors:  Ary Serpa Neto; Ignacio Martin Loeches; Robert B Klanderman; Raphael Freitas Silva; Marcelo Gama de Abreu; Paolo Pelosi; Marcus J Schultz
Journal:  Ann Transl Med       Date:  2017-08

Review 5.  Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Authors:  Carmen A Pfortmueller; Barbara Kabon; Joerg C Schefold; Edith Fleischmann
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

Review 6.  Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.

Authors:  Sohail Bampoe; Peter M Odor; Ahilanandan Dushianthan; Elliott Bennett-Guerrero; Suzie Cro; Tong J Gan; Michael Pw Grocott; Michael Fm James; Michael G Mythen; Catherine Mn O'Malley; Anthony M Roche; Kathy Rowan; Edward Burdett
Journal:  Cochrane Database Syst Rev       Date:  2017-09-21

Review 7.  Preventing neurological complications from dysnatremias in children.

Authors:  Michael L Moritz; J Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

8.  Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke.

Authors:  Alexander Papangelou; Thomas J K Toung; Allan Gottschalk; Marek A Mirski; Raymond C Koehler
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

9.  Key Controversies in Colloid and Crystalloid Fluid Utilization.

Authors:  Erin N Frazee; David D Leedahl; Kianoush B Kashani
Journal:  Hosp Pharm       Date:  2015-06

10.  Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution.

Authors:  Thomas J Morgan; Balasubramanian Venkatesh; Jonathan Hall
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.